Raymond James Financial Inc. Raises Holdings in GRAIL, Inc. $GRAL

Raymond James Financial Inc. raised its position in GRAIL, Inc. (NASDAQ:GRAL - Free Report) by 354.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 121,169 shares of the company's stock after buying an additional 94,518 shares during the quarter. Raymond James Financial Inc. owned about 0.34% of GRAIL worth $3,095,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in GRAL. Sessa Capital IM L.P. bought a new stake in shares of GRAIL in the fourth quarter valued at $53,550,000. Jacobs Levy Equity Management Inc. bought a new stake in shares of GRAIL during the 4th quarter valued at $18,209,000. Wealthquest Corp bought a new stake in shares of GRAIL during the 1st quarter valued at $18,247,000. Bank of America Corp DE bought a new stake in shares of GRAIL during the 4th quarter valued at $10,638,000. Finally, Newtyn Management LLC bought a new stake in shares of GRAIL during the 4th quarter valued at $7,140,000.

Insiders Place Their Bets

In other GRAIL news, President Joshua J. Ofman sold 9,692 shares of the company's stock in a transaction dated Monday, June 30th. The stock was sold at an average price of $52.00, for a total value of $503,984.00. Following the transaction, the president directly owned 492,076 shares in the company, valued at $25,587,952. This represents a 1.93% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Aaron Freidin sold 8,000 shares of the company's stock in a transaction dated Tuesday, July 15th. The stock was sold at an average price of $38.93, for a total value of $311,440.00. Following the completion of the transaction, the chief financial officer owned 286,020 shares in the company, valued at $11,134,758.60. This represents a 2.72% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 361,694 shares of company stock worth $17,780,266 in the last ninety days. 1.85% of the stock is currently owned by insiders.

GRAIL Stock Down 1.6%

Shares of NASDAQ:GRAL traded down $0.61 during midday trading on Friday, reaching $38.04. 519,444 shares of the company traded hands, compared to its average volume of 678,706. GRAIL, Inc. has a 12 month low of $12.33 and a 12 month high of $63.99. The firm has a market capitalization of $1.37 billion, a price-to-earnings ratio of -2.90 and a beta of 3.18. The firm's fifty day moving average price is $35.66 and its two-hundred day moving average price is $35.52.

GRAIL (NASDAQ:GRAL - Get Free Report) last released its quarterly earnings data on Tuesday, August 12th. The company reported ($3.18) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($3.14) by ($0.04). GRAIL had a negative net margin of 329.86% and a negative return on equity of 16.64%. The company had revenue of $35.54 million for the quarter, compared to the consensus estimate of $37.57 million. Analysts forecast that GRAIL, Inc. will post -15.15 earnings per share for the current year.

GRAIL Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.